Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018


Posted on: 08 May 18

NASHUA, N.H., May 08, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it will release financial results for the first quarter ended March 31, 2018 after the close of the market, and host a conference call at 4:30pm Eastern Time, on Monday, May 14, 2018.

Monday, May 14th @ 4:30pm Eastern Time
Domestic: (800) 239-9838
International:     (323) 794-2551
Conference ID: 8849802
Webcast: http://public.viavid.com/index.php?id=129486
   
Replays, available through May 28th
Domestic:  (844) 512-2921
International: (412) 317-6671
Replay PIN: 8849802
   

In addition, a replay of the call will remain on the Company’s website (www.icadmed.com) until the Company releases its second quarter 2018 financial results. 

About iCAD, Inc.
iCAD delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and faster while improving patient outcomes. iCAD offers a comprehensive range of upgradeable computer aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers. iCAD’s Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is a painless, non-invasive technology that delivers high dose rate, low energy radiation, which targets cancer while minimizing exposure to surrounding healthy tissue. The Xoft System is FDA cleared and CE marked for use anywhere in the body, including treatment of non-melanoma skin cancer, early-stage breast cancer and gynecological cancers. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection and radiation therapy treatments. For more information, visit or www.icadmed.com or www.xoftinc.com.

CONTACTS:

Media Inquiries:
ARPR, LLC
Erin Bocherer
(855) 300-8209 x120
erin@arpr.com

or

Investor Relations:
LifeSci Advisors
Jeremy Feffer
(212) 915-2568
jeremy@lifesciadvisors.com

GlobeNewswire
globenewswire.com

Last updated on: 08/05/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.